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Background: The prevalence of infections caused by Cefotaximase-Munich (CTX-M)-type extended-spectrum
beta-lactamase-producing Enterobacteriaceae (ESBL-E) has rapidly increased during the past 15 years.
Enterobacteriaceae are commonly found in the gastrointestinal tract and long-term intestinal carriage is
considered important for the spread of ESBL and as a source of clinical infections. Oral biofilm such as
supragingival plaque is known to contain numerous antibiotic resistance determinants and may also represent a
poorly investigated site for ESBL carriage and further spread.
Objective: To investigate possible carriage of ESBL-producing bacteria in supragingival plaque of known
fecal carriers of these bacteria.
Design: We screened for the presence of aerobic and anaerobic ESBL-producing bacteria and blaCTX-M in
supragingival plaque samples from healthy human adults with culture-verified fecal carriage of CTX-M-
producing Escherichia coli. The presence or absence of Enterobacteriaceae and ESBL-producing bacteria in
plaque samples was evaluated using culture-based methods and consensus CTX-M PCR.
Results: Oral samples were obtained from 17 participants with known previous carriage of ESBL-producing
E. coli. No ESBL-producing bacteria or ESBL genes were detected using culture-based and molecular
methods. One colony of Rahnella aquatilis harboring the class A ESBL gene blaRAHN-1/2 was identified in an
oral sample from one of the participants.
Conclusion: This pilot study supports the notion that the presence of CTX-M-producing bacteria is uncommon
in oral plaque of healthy human adult fecal carriers. Due to the limited number of persons tested, a low
prevalence of oral ESBL-carriage in healthy adults or carriage in selected groups of patients cannot be excluded.
To our knowledge, this is the first description of an R. aquatilis with the RAHN-1/2 gene in the oral cavity.
Keywords: CTX-M; oral carriage; extended-spectrum b-lactamase; Enterobacteriaceae
Responsible Editor: Clay B. Walker, University of Florida, USA.
*Correspondence to: Arne Søraas, Department of Medical Microbiology, Vestre Viken Hospital Trust,
3004 Drammen, Norway, Email: arne@meg.no
Received: 9 April 2014; Revised: 6 July 2014; Accepted: 7 July 2014; Published: 20 August 2014
T
he spread of genes coding for CTX-M-type
extended-spectrum beta-lactamases (ESBLs) among
Enterobacteriaceae has increased dramatically
worldwide and is a major public health concern (1). It is
thought that more than one billion people are intesti-
nally colonized with ESBL-producing Enterobacteriaceae
(ESBL-E) and that major drivers of the dissemination of
these strains are antibiotic use in humans and animals
and dissemination of antibiotic residues and ESBL-E in
the environment (2, 3). Patients with infections caused by
ESBL-E are known to suffer from increased morbidity
and mortality compared to patients with infections caused
by non-ESBL-E (4). Escherichia coli is the most com-
mon pathogenic bacterium among Enterobacteriaceae in
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human disease and causes serious and common infections
such as septicemia and urinary tract infection (UTI) (5).
E. coli is also the most commonly occurring ESBL-
producing pathogen and has the gastrointestinal tract as
its primary habitat (6). Secondary environmental habitats
such as water and sediments are also known and the
human oral cavity and oropharynx may also be considered
important secondary habitats (6).
The large increase in the worldwide prevalence of
CTX-M-type ESBL-E has been driven by horizontally
transmitted genes carried by promiscuous plasmids and
successful bacterial clones, but much is still unclear about
the transmission of Enterobacteriaceae between hosts
(7, 8). The presence of ESBL genes in the oral cavity,
either harbored in Enterobacteriaceae or in other oral
bacteria, might act as reservoirs of ESBL which may be
shed to the intestinal tract and externally as airborne
particles or through direct contact. Thus, oral carriage
might influence important epidemiological parameters of
ESBLs like duration of carriage and mode of transfer.
While the fecaloral route of transmission of these
pathogens has been thoroughly explored in the literature,
less attention has been given to airborne or oraloral
transmission.
Transient or longer term carriage of Enterobacteriaceae
in the oral cavity or oropharynx has been linked to
hospitalized patients and patients with periodontal dis-
ease, but may also be present in healthy individuals. One
review of literature by Mobbs et al. found that the
prevalence of oropharyngeal gram-negative bacilli in
healthy individuals in 36 studies ranged from 0 to 61.1%
(9). This study also sampled 120 individuals two times
separated by 48 hours and found gram-negative bacilli in
36% of the cases, but in only 6.6% of the individuals the
strains were identical between samples indicating a high
frequency of transient carriage and thus rapid clearance of
these species from the oral cavity and oropharynx. This
may not to be the case in hospitalized patients and
Johanson et al. found colonization rates up to 73% in
severely ill (moribund) patients. In a more recent study
Filius et al. also found that colonization was associated
with severity of illness and in oropharyngeal samples it
was 1.1% and 18% at admittance to general wards or
intensive care units (ICU), respectively (10). The latter
study also found that the prevalence increased signifi-
cantly during and after hospitalization. Both the studies
by Johanson et al. and Filius et al. suggest that orophar-
yngeal clearance of gram-negative bacilli is impeded in
(severely) ill patients. Oral carriage of Enterobacteriaceae
has also been associated with chronic periodontitis and an
increase related to antibiotic use has been seen in this
group (1113). One would expect this increase to be even
more pronounced for ESBL-E because of their (often
multiple) resistance mechanisms. Enterobacteriaceae sur-
vive in air and on surfaces; thus, it is possible that the
impact of airborne or oraloral transmission of these
bacteria has been underestimated  especially in high-risk
situations in hospitals, but also in the general population
(14).
Large studies have shown that the oral cavity includes
several microbiological distinct niches with their own
characteristic microbiota, including a wide variety of
resistance determinants also encoding beta-lactamases
(1520). The oral microbiota is in constant interaction
with the external environment and bacteria descending
to the gut must pass through this area. Thus, a two-way
exchange of resistance determinants between food and
drink and the oral microbiota is likely to occur (18, 19).
The oral cavity therefore possesses many characteristics
necessary for a flexible transmission of genes, including
ESBL-encoding genes from the environment to a host,
between bacteria in a host or between hosts.
We aimed at determining the extent of oral carriage
of ESBL in intestinal carriers of ESBL-E in a pilot study.
We considered supragingival plaque the most likely oral
location of ESBL-E and therefore sampled this area from
known fecal carriers of E. coli carrying the ESBL gene
blaCTX-M and examined these for ESBL-producing bac-
teria and blaCTX-M. To our knowledge, the prevalence
of oral carriage of ESBL in known intestinal carriers
of ESBL-producing bacteria has not been investigated
previously.
Materials and methods
Setting and design
As part of a study on fecal carriage of ESBL-producing
E. coli or Klebsiella pneumonia associated with UTI, supra-
gingival plaque and repeat fecal samples were collected
from known fecal carriers of these bacteria. The study was
conducted at the Department of Medical Microbiology at
Vestre Viken Hospital Trust in Eastern Norway and the
Department of Oral Biology, University of Oslo.
The study was approved by the South-Eastern Norway
Regional Committee for Medical and Health Research
Ethics following the Declaration of Helsinki principles
(1975, 1983) (reference number: 2009/2037 BS-08901b).
Written informed consent was obtained from all partici-
pants and donation of the supragingival plaque sample
was not mandatory for participation in the other parts of
the study.
Participants
The participants were adult volunteers from a study on
fecal carriage of ESBL and risk factors for UTI caused by
ESBL-producing E. coli or K. pneumoniae (21, 22). In this
study, inclusion criteria were patients with community-
acquired UTI caused by these bacteria or their household
members. The patients were recruited after their urine had
been submitted to a microbiological laboratory for analysis.
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Participants were interviewed; they submitted fecal samples
and data were collected from the Norwegian Prescrip-
tion Registry and patient medical records. During one time
period in 2010 and one in 2011 participants with a fecal
sample yielding ESBL-producing E. coli or K. pneumoniae
were invited by mail to donate a supragingival plaque sample
in a clinical setting. Periodontal status or antibiotic use was
not known at the time of inclusion. The following exclusion
criteria were used: 1) patients who had lived in Norway for
B1 year, 2) were unable to answer our questionnaire, 3) had
a previously diagnosed infection caused by ESBL-producing
bacteria, and 4) patients with health care associated UTI
(i.e. hospitalized or residing in a nursing home for 24
hours during the last 31 days). Sample collection was
performed in two batches.
Sample collection and analysis
Fecal samples
Fecal samples were collected by the participants them-
selves using a sterile cotton swab applied to the toilet paper
after defecation. The sample containers were returned by
ordinary mail and cultured aerobically on ESBL selective
agar plates (ChromID ESBL, BioMerieux, Marcy l’Etoile,
France), enriched in a selective broth with 2.5 mg/ml of
cefotaxime and then grown on the ESBL selective agar
plates and on a non-selective lactose agar plate as growth
control. Species identification was based on characteristic
pink to burgundy oxidase-negative colonies for E. coli.
Species identification of green colonies was obtained
using the VITEK-2 system (GN ID card, BioMerieux).
Genotypic verification of ESBL and phylogroup assign-
ment of fecal ESBL-positive isolates was performed using
polymerase chain reaction (PCR) as described earlier
(23). Sub-typing of fecal ESBL-producing E. coli isolates
was performed by ten-loci multiple-locus variable-number
tandem-repeat analysis (MLVA) as described earlier
(24, 25).
Oral plaque samples
Supragingival plaque samples were collected at the
Department of Oral Biology, University of Oslo by a
non-calibrated, but clinically experienced dentist with
sterile Gracey-designed steel curettes (Stalan GMBH,
Ahrensburg, Germany). Samples were taken from the
mesio-buccal site of every tooth, with one vertical stroke
in participants with their own teeth intact. Patients were
not screened for periodontal disease site by site, but
periodontal probing was done to make sure what pockets
were healthy (B3 mm). Anamnestic occurrence of period-
ontal disease was recorded. From participants with dental
prostheses or implants, biofilms were collected from these
restorations. The samples were immediately transferred to
one 5.5 ml vial of a pre-reduced anaerobically sterilized
transport medium (Dental Transport Medium, Anaerobic
System, Morgan Hill, CA) per patient (i.e. all samples
from each patient were pooled). This is a medium in which
also facultative organisms will survive. The samples
were then homogenized within four hours by vortex and
plated onto McConkey agar plates, ChromID ESBL
(BioMerieux) and blood agar plates (nonselective trypti-
case soy agar supplemented with 5% defibrinated human
blood, hemin 5 mg/ml, and menadione 0.05 mg/ml) and
incubated at 378C for 2448 hours in aerobic (McConkey
and ChromID ESBL) and anaerobic (90% N2, 5% H2, 5%
CO2) conditions (blood agar plates). Species identification
of suspected Enterobacteriaceae was obtained using the
VITEK-2 system (GN ID card, BioMerieux).
For PCR, 100 ml of the inoculated transport medium
was diluted in 100 ml of Tris EDTA buffer and frozen
at 708C. DNA was extracted using MasterPure DNA
Purification Kit (Epicentre, Madison, WI) according to
the instructions of the manufacturer. PCR was performed
in duplicate using the same procedure as for the fecal
samples (23).
Sensitivity of PCR
To semi-quantitatively assess the sensitivity of the DNA
extraction and PCR procedure described for oral plaque
samples, 10-fold dilutions of CTX-M 1 producing E. coli
(CCUG 55971) were inoculated in dental transport
medium. DNA extraction and PCR were performed as
described for the oral samples above. The detection limit
of the DNA extraction- and PCR procedures from the
dental samples were found to be 330 gene copies per
PCR run indicating a lower detection limit of approxi-
mately 1,60016,000 ESBL gene copies per supragingival
plaque sampling procedure. The approximation assumed
the same copy number of blaCTX-M genes in the clinical
isolates as in the reference strain E. coli (CCUG 55971).
Results
Patient characteristics and results from culture- and
molecular analyses of fecal and oral samples are presented
in Table 1. A total of 17 participants were enrolled in the
study. The mean age was 61 years (range 2384) and 13
(76%) participants were female. The median Charlson
index score was 1 and data from the prescription registry
showed that seven out of 17 participants (59%) had been
on one or more courses of antibiotics during the 3 months
before the oral sample was obtained.
Fecal samples
Fecal carriage of ESBL-E was a prerequisite for inclusion
and therefore present in all participants. At least one
follow-up fecal sample was obtained after dental sam-
pling from 14 of the 17 (82%) participants. The ESBL
determinants in inclusion- and follow-up samples were
harbored exclusively in E. coli and of the 17 inclusion
isolates, 12 belonged to CTX-M phylogroup 1 and five
to CTX-M phylogroup 9. The median duration from
the inclusion sample to dental sampling was 64 days
ESBL-producing Enterobacteriaceae
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(range 8326 days). The first follow-up sample from each
participant was obtained at median 55 days (range 3768
days) after dental sampling.
Results from 17 participants
1. In six (35%) participants, the same ESBL phylogroup
and MLVA profile were identified in both the
inclusion and follow-up sample.
2. In two (12%) participants with the same phylogroup,
the MLVA profile diverged in four and seven
loci.
3. In one (6%) participant, the same phylogroup was
only detected in the third fecal sample after dental
sampling and at that point the MLVA profile
diverged in four loci.
4. Six (35%) participants did not donate a follow-up
fecal sample or donated a sample more than 700 days
after the dental procedure and all of these were
negative.
5. Two (12%) participants donated fecal samples
promptly after the dental procedure, but these and
later samples were CTX-M-negative.
Of the nine fecal ESBL culture-positive isolates obtained
after the dental procedure, seven isolates belonged to
CTX-M phylogroup 1, one to CTX-M phylogroup 9 and
in one participant both CTX-M 1 and 9 were identified.
Oral plaque samples
Of the 17 participants, 15 had their own teeth, one had
a combination of own teeth and implants and one had
a dental prosthesis only. Two patients had a history of
marginal periodontitis. All oral samples were culture-
positive on the blood agar plates. No ESBL-producing
oral bacteria were detected by culturing on the ChromID
ESBL.
Enterobacteriaceae were isolated from the McConkey
cultures in three patients (17.6%). From these three par-
ticipants, four different Enterobacteriaceae strains were
Table 1. Background information about participants and time of fecal sample before and after the oral sampling procedure and
results from these samples
ID Age
Gender
(F/M)
Number of days from
collection of fecal
sample to collection
of oral sample
Number of days
from oral
sampling to next
fecal sample
Phylogroup of CTX-M-
genes from fecal
sample before oral
samplinga
Phylogroup of CTX-M-
genes from fecal
sample obtained after
oral samplinga
MLVA resultsb
(number of diverging
loci before and after
dental sampling)
1 64 M 8 81 1 1 0
2 65 F 11 81 1 1 0
3c 73 F 11 80 1 1 7
4 45 F 14 90 1 1 0
5 74 F 38  1  NA
6 52 F 44 13 9 9 0
7 23 F 56 16 1 1 4
8 84 F 57 13 1 Negative NA
9d 69 F 64 6 1 1 0
10e 50 F 71 17 1 Negative NA
11 68 M 74 726 9 Negative NA
12 70 M 77 706 9 Negative NA
13 59 M 100  1  NA
14 42 F 122 768 1 Negative NA
15 75 F 148 29 1 1 0
16 45 F 186 3 9 Negativef 4
17 79 F 326  9  NA
ID: study participant number; F/M: female or male gender; CTX-M: Cefotaximase-Munich; MLVA: ten-loci multiple-locus variable-number
tandem-repeat analysis; NA: not available.
aAll the CTX-M genes identified prior to, and directly after oral sampling were harbored in E. coli. They were all assigned to phylogroups
1 or 9.
bMLVA was used for comparison of E. coli isolates in patients with more than one isolate. A low number of diverging loci indicate that the
compared strains were identical or closely related.
cPatient had dental prosthesis.
dPatient had marginal periodontitis and four dental implants.
ePatient had marginal periodontitis.
f97 days later CTX-M 1 was detected and 145 days later CTX-M 1 and 9 were detected.
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identified, whereas none of the patients suffered from
periodontitis. The strains were identified as Rahnella
aquatilis (n1), Pantoea sp. (n2) and Enterobacter
cloacae (n1).
Classical ESBLs were not identified by PCR in any
of the oral plaque samples, but the R. aquatilis strain
harbored the class A ESBL gene blaRAHN-1/2 by PCR
(26).
Discussion
We have investigated the oral cavity as a potential
reservoir for the CTX-M-type ESBL resistance determi-
nants in adults with fecal carriage of CTX-M producing
E. coli using culture-based and molecular methods. The
negative results obtained do not support the oral cavity as
a significant reservoir of CTX-M-type ESBL.
The sensitivity of the molecular methods and ChromID
ESBL agar plates used for detection of ESBL-E is high
(27). Furthermore, we sampled supragingival plaque be-
cause this is the oral location we considered most likely to
harbor Enterobacteriaceae. Thus, ESBL-producing strains
or blaCTX-M should have been detected, if present in the
oral samples from our participants. The negative results
indicate the absence or presence in low concentrations
only, of oral ESBLs in intestinal carriers and corroborate
previous studies that have found a relatively low abun-
dance of Enterobacteriaceae in the healthy oral cavity. The
present study does not indicate that the oral carriage
dynamics of ESBL-E is different from non-ESBL-E. The
negative PCR results also suggest that classical CTX-M
genes are not harbored in any of the many different oral
bacterial species present in oral samples.
Our result on oral carriage elucidates the difference
between fecal and oral carriage of ESBL-E. A recent
study by Titelman et al. investigated the duration of fecal
carriage after ESBL-E infections and found a gastro-
intestinal carriage rate of 66% three months after, and
43% one year after infection (28). The difference between
oral and fecal carriage duration is probably a result of the
oral cavity being a microbiological site distinctly different
from the gastrointestinal tract. In one study, 509 different
bacteria were detected in periodontal samples, but only
29 of these were found among the 560 intestinal- or fecal
bacteria isolated, illustrating this point (29). Furthermore,
to our knowledge only narrow spectrum beta-lactamases,
AmpC beta-lactamases or unspecified TEM-genes have
been detected in plaque of patients with periodontitis or in
plaque samples from the normal population (20, 3032).
The R. aquatiliswith the ESBL gene blaRAHN-1/2 identified
in the present material is thus, to our knowledge, a novelty.
However, R. aquatilis is probably a transient bacterium in
the mouth originating from drinking water (33). Support-
ing this, it was not identified in the patient’s fecal samples,
and this finding does not change the overall picture of
intestinal ESBL carriage as not related to oral carriage.
The present study does not support the oral cavity as a
source of transmission of ESBL. But worryingly, after
doxycycline therapy more than a 10-fold increase was seen
in subgingival numbers of Enterobacter aerogenes and
E. coli (13). Another study showed an increasing frequency
of nasal and pharyngeal carriage of Enterobacteriaceae
during the hospitalized period in patients admitted to
general wards and intensive care units (10). Thus, ESBL-E
may under certain circumstances be more frequent in the
oropharyngeal area than our study demonstrated. Possible
transmission related to oropharyngeal carriage was de-
monstrated in another study by Branger et al., which
identified an outbreak of ESBL-E possibly related to
a poorly maintained bronchoscope (34). Thus, there are
suggestions that periods of oral- or upper airway carriage
may facilitate the transfer of ESBL-E, but this remains to
be documented. In hospitals, where oral and orophar-
yngeal carriage appears to be more frequent, this may have
serious consequences due to inter-patient transmission.
The present results apply to non-hospitalized fecal carriers
of ESBL-E and should not discourage infectious control
measures that take into account a possible oropharyngeal
source of ESBL-E (10).
Our study has limitations of which the most important
is its small size. Furthermore, the intestinal colonization
status of the participants at the exact time of the dental
sampling procedure was unknown since fecal samples
were not collected at that time. However, ESBL was
detected in 9 of 11 (82%) participants that donated a fecal
sample within 90 days after dental sampling. This is in
line with published data on the duration of fecal ESBL
carriage after infection (28). The exact same ESBL or
E. coli MLVA sub-type was not identified in all nine par-
ticipants. This may be explained by re-colonization and
thus it is a possibility that these participants were not
fecal carriers at the time of the dental procedure. Since
Norway is a country with a low prevalence of ESBL,
this seems unlikely. Other explanations like initial co-
colonization with several ESBLs, transfer of plasmids
between E. coli strains and ESBL below the detection
threshold seem better explanations for diverging phy-
logroups and sub-types before and after dental sampling.
It’s not possible to know how many participants were
actually fecal carriers at the time of oral sampling, yet an
estimate based on the 11 participants who did donate a
fecal sample within 90 days of the oral sampling is 14 of 17.
Given that 20% of fecal ESBL-E carriers are also oral
carriers, the chance of a negative result in 14 individuals is
less than 5% (0.8014B0.05), indicating that the true oral
carriage rate in fecal ESBL-E carriers is lower than this.
Furthermore, none of the 17 previously known fecal
carriers of ESBL were found to be oral carriers at a
median of 64 days after fecal sampling. At this point in
time, at least 66% of patients infected with ESBL-E would
be expected to be fecal carriers according to one earlier
ESBL-producing Enterobacteriaceae
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study (28). Thus, we may make a cautious conclusion that
the frequency of fecal carriage is significantly higher than
oral carriage after a UTI caused by ESBL-E (pB0.001,
Fisher’s exact test). The results do not rule out transient
oral ESBL-carriage in fecal carriers or oral carriage in
high-risk groups like hospitalized patients. Because of the
limitations of this pilot study and the importance of the
issue investigated, further studies of oral carriage of ESBL
are warranted.
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